Dementia With Lewy Bodies Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Phase 2
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
Dementia With Lewy Bodies
Georgetown University60 enrolled1 locationNCT04002674
Recruiting
Phase 2
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Dementia With Lewy Bodies
Georgetown University45 enrolled1 locationNCT03996460